606 related articles for article (PubMed ID: 9222099)
1. Comparative analysis of different permeabilization methods for the flow cytometry measurement of cytoplasmic myeloperoxidase and lysozyme in normal and leukemic cells.
Lanza F; Latorraca A; Moretti S; Castagnari B; Ferrari L; Castoldi G
Cytometry; 1997 Jun; 30(3):134-44. PubMed ID: 9222099
[TBL] [Abstract][Full Text] [Related]
2. Intracellular markers in acute myeloid leukemia diagnosis.
Koníková E; Glasová M; Kusenda J; Babusíková O
Neoplasma; 1998; 45(5):282-91. PubMed ID: 9921916
[TBL] [Abstract][Full Text] [Related]
3. Comparison of myeloperoxidase detection by flow cytometry using two different clones of monoclonal antibodies.
Leong CF; Kalaichelvi AV; Cheong SK; Hamidah NH; Rahman J; Sivagengei K
Malays J Pathol; 2004 Dec; 26(2):111-6. PubMed ID: 16329563
[TBL] [Abstract][Full Text] [Related]
4. Rapid single-step method for flow cytometric detection of surface and intracellular antigens using whole blood.
Francis C; Connelly MC
Cytometry; 1996 Sep; 25(1):58-70. PubMed ID: 8875055
[TBL] [Abstract][Full Text] [Related]
5. High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis.
Graf M; Reif S; Hecht K; Pelka-Fleischer R; Pfister K; Schmetzer H
Am J Hematol; 2005 May; 79(1):26-35. PubMed ID: 15849776
[TBL] [Abstract][Full Text] [Related]
6. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
Klobusicka M; Kusenda J; Babusikova O
Neoplasma; 2005; 52(3):211-8. PubMed ID: 15875082
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of three permeabilization methods for cytofluorometric evaluation of cytoplasmic myeloperoxidase.
Tay SP; Cheong SK; Hamidah NH; Ainoon O
Malays J Pathol; 1999 Jun; 21(1):37-43. PubMed ID: 10879277
[TBL] [Abstract][Full Text] [Related]
8. [Flow cytometric analysis of myeloperoxidase negative acute unclassifiable leukemias by monoclonal antibodies. Acute myelogenous and acute megakaryocytic leukemia].
Imamura N; Kuramoto A; Kawaguchi Y; Tanaka R
Rinsho Ketsueki; 1989 Jan; 30(1):11-21. PubMed ID: 2541276
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric detection of intracellular antigens for immunophenotyping of normal and malignant leukocytes.
Groeneveld K; te Marvelde JG; van den Beemd MW; Hooijkaas H; van Dongen JJ
Leukemia; 1996 Aug; 10(8):1383-9. PubMed ID: 8709649
[TBL] [Abstract][Full Text] [Related]
10. Clinical value of the quantitative expression of the three epitopes of CD34 in 300 cases of acute myeloid leukemia.
Maynadié M; Gerland L; Aho S; Girodon F; Bernier M; Brunet C; Campos L; Daliphard S; Deneys V; Falkenrodt A; Jacob MC; Kühlein E; LeCalvez G; Moskovtchenko P; Philip P; Carli PM; Faure GC; Béné MC;
Haematologica; 2002 Aug; 87(8):795-803. PubMed ID: 12161354
[TBL] [Abstract][Full Text] [Related]
11. Comparison of fluorescein and phycoerythrin conjugates for quantifying CD20 expression on normal and leukemic B-cells.
Wang L; Abbasi F; Gaigalas AK; Vogt RF; Marti GE
Cytometry B Clin Cytom; 2006 Nov; 70(6):410-5. PubMed ID: 16967494
[TBL] [Abstract][Full Text] [Related]
12. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M
Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of acute myeloid leukemia and system Coulter VCS.
Bruno A; Del Poeta G; Venditti A; Stasi R; Adorno G; Aronica G; Suppo G; Di Rienzo AM; Iazzoni R; Tribalto M
Haematologica; 1994; 79(5):420-8. PubMed ID: 7843628
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of MPO and lysozyme antibodies in acute leukemia. Implications for the definition of FAB subtypes using a flow cytometric approach in combination with different permeabilising methods.
Latorraca A; Lanza F; Ferrari L; Castoldi GL
Eur J Histochem; 1997; 41 Suppl 2():27-8. PubMed ID: 9859768
[No Abstract] [Full Text] [Related]
15. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic quantitative features of patients with acute myeloid leukemia.
Pereira FG; Metze K; Costa FP; Lima CS; Lorand-Metze I
Neoplasma; 2006; 53(2):155-60. PubMed ID: 16575472
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric detection of intracellular myeloperoxidase, CD3 and CD79a. Interaction between monoclonal antibody clones, fluorochromes and sample preparation protocols.
Kappelmayer J; Gratama JW; Karászi E; Menéndez P; Ciudad J; Rivas R; Orfao A
J Immunol Methods; 2000 Aug; 242(1-2):53-65. PubMed ID: 10986389
[TBL] [Abstract][Full Text] [Related]
18. Antibody-producing human-human hybridomas. III. Derivation and characterization of two antibodies with specificity for human myeloid cells.
Andreasen RB; Olsson L
J Immunol; 1986 Aug; 137(3):1083-90. PubMed ID: 3459756
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometry measurement of GM-CSF receptors in acute leukemic blasts, and normal hemopoietic cells.
Lanza F; Castagnari B; Rigolin G; Moretti S; Latorraca A; Ferrari L; Bardi A; Castoldi G
Leukemia; 1997 Oct; 11(10):1700-10. PubMed ID: 9324292
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemistry can be used to subtype acute myeloid leukemia in routinely processed bone marrow biopsy specimens. Comparison with flow cytometry.
Manaloor EJ; Neiman RS; Heilman DK; Albitar M; Casey T; Vattuone T; Kotylo P; Orazi A
Am J Clin Pathol; 2000 Jun; 113(6):814-22. PubMed ID: 10874882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
